Extendicare Inc.

OTCPK:EXET.F Stock Report

Market Cap: US$2.1b

Extendicare Past Earnings Performance

Past criteria checks 4/6

Extendicare has been growing earnings at an average annual rate of 47.2%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 9.9% per year. Extendicare's return on equity is 30%, and it has net margins of 6.1%.

Key information

47.16%

Earnings growth rate

47.30%

EPS growth rate

Healthcare Industry Growth8.50%
Revenue growth rate9.88%
Return on equity29.96%
Net Margin6.13%
Last Earnings Update30 Jun 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Extendicare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:EXET.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 261,979121650
31 Mar 261,751122630
31 Dec 251,66097610
30 Sep 251,59091590
30 Jun 251,50983580
31 Mar 251,47477570
31 Dec 241,46675570
30 Sep 241,42564570
30 Jun 241,38859570
31 Mar 241,34735570
31 Dec 231,30534560
30 Sep 231,26518540
30 Jun 231,2521530
31 Mar 231,2413520
31 Dec 221,222-5510
30 Sep 221,217-1550
30 Jun 221,1936510
31 Mar 221,1784530
31 Dec 211,1678520
30 Sep 211,11427490
30 Jun 211,12659510
31 Mar 211,12749470
31 Dec 201,10442450
30 Sep 201,14131420
30 Jun 201,1272410
31 Mar 201,12915410
31 Dec 191,13215410
30 Sep 191,1301410
30 Jun 191,1274420
31 Mar 191,1236410
31 Dec 181,1208400
30 Sep 181,11327370
30 Jun 181,10626370
31 Mar 181,10030370
31 Dec 171,09732380
30 Sep 171,09335400
30 Jun 171,08838380
31 Mar 171,07538370
31 Dec 161,06131370
30 Sep 161,04625380
30 Jun 161,03227380
31 Mar 161,00521380
31 Dec 1594324360
30 Sep 1589424330

Quality Earnings: EXET.F has high quality earnings.

Growing Profit Margin: EXET.F's current net profit margins (6.1%) are higher than last year (5.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: EXET.F's earnings have grown significantly by 47.2% per year over the past 5 years.

Accelerating Growth: EXET.F's earnings growth over the past year (45.8%) is below its 5-year average (47.2% per year).

Earnings vs Industry: EXET.F earnings growth over the past year (45.8%) exceeded the Healthcare industry 20.8%.

Return on Equity

High ROE: Whilst EXET.F's Return on Equity (29.96%) is high, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 05:12
End of Day Share Price 2026/09/08 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Extendicare Inc. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyle McPheeATB Cormark
Tom CallaghanBMO Capital Markets Equity Research
Tania Armstrong-WhitworthCanaccord Genuity